利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

7 条记录 (耗时 0.04 秒)

    Management and treatment of benign prostatic hyperplasia
    1.
    发明授权
    Management and treatment of benign prostatic hyperplasia 有权
    良性前列腺增生的治疗与治疗

    公开(公告)号：US09061023B2

    公开(公告)日：2015-06-23

    申请号：US12734373

    申请日：2008-04-08

    申请人： Gerda Fouche ,  Vinesh Jaichand Maharaj ,  Xolani Mthembu ,  Louis Ackerman ,  Marina Van Der Merwe

    发明人： Gerda Fouche ,  Vinesh Jaichand Maharaj ,  Xolani Mthembu ,  Louis Ackerman ,  Marina Van Der Merwe

    IPC分类号： A61K36/00 ,  A61K36/48

    CPC分类号： A61K36/48

    摘要： The invention provides the use of an extract of a plant of the genus Elephantorrhiza and at least one compound selected from quercitin-3′-O-glucoside, trans-3-O-galloyl-3,3′,5,5′,7-pentahydroxyflavan, taxifolin-3′-O-glucoside, catechin and epicatechin in the preparation of a medicament for the treatment of benign prostatic hyperplasia (BPH). The mode of action is by a route selected from blocking the conversion of testosterone to dihydrotestosterone by inhibiting the 5α-reductase enzyme or by reducing oxidative stress or both.

    摘要翻译： 本发明提供了Elephantorrhiza植物提取物和至少一种选自槲皮素-3'-O-葡萄糖苷，反式-3-O-加酰基-3,3'，5,5'，7 - 五羟基黄烷，紫杉紫素-3'-O-葡萄糖苷，儿茶素和表儿茶素在制备用于治疗良性前列腺增生（BPH）的药物中的用途。 作用方式是选择通过抑制5α还原酶或减少氧化应激或两者阻断睾酮转化为二氢睾酮的途径。

    MANAGEMENT AND TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
    2.
    发明申请
    MANAGEMENT AND TREATMENT OF BENIGN PROSTATIC HYPERPLASIA 有权
    BENIGN PROSTATIC HYPERPLASIA的管理与处理

    公开(公告)号：US20100316748A1

    公开(公告)日：2010-12-16

    申请号：US12734373

    申请日：2008-04-08

    申请人： Gerda Fouche ,  Vinesh Jaichand Maharaj ,  Xolani Mthembu ,  Louis Ackerman ,  Marina Van Der Merwe

    发明人： Gerda Fouche ,  Vinesh Jaichand Maharaj ,  Xolani Mthembu ,  Louis Ackerman ,  Marina Van Der Merwe

    IPC分类号： A61K36/48 ,  C07H15/26 ,  A61K31/7028 ,  A61P13/10

    CPC分类号： A61K36/48

    摘要： The invention provides the use of an extract of a plant of the genus Elephantorrhiza and at least one compound selected from quercitin-3′-O-glucoside, trans-3-O-galloyl-3,3′,5,5′,7-pentahydroxyflavan, taxifolin-3′-O-glucoside, catechin and epicatechin in the preparation of a medicament for the treatment of benign prostatic hyperplasia (BPH). The mode of action is by a route selected from blocking the conversion of testosterone to dihydrotestosterone by inhibiting the 5α-reductase enzyme or by reducing oxidative stress or both.

    摘要翻译： 本发明提供了Elephantorrhiza植物提取物和至少一种选自槲皮素-3'-O-葡萄糖苷，反式-3-O-加酰基-3,3'，5,5'，7 - 五羟基黄烷，紫杉紫素-3'-O-葡萄糖苷，儿茶素和表儿茶素在制备用于治疗良性前列腺增生（BPH）的药物中的用途。 作用方式是选择通过抑制5α还原酶或减少氧化应激或两者阻断睾酮转化为二氢睾酮的途径。

    Treatment of erectile dysfunction and libido enhancement
    4.
    发明授权
    Treatment of erectile dysfunction and libido enhancement 有权
    治疗勃起功能障碍和性欲增强

    公开(公告)号：US08609151B2

    公开(公告)日：2013-12-17

    申请号：US12302086

    申请日：2007-05-23

    申请人： Gerda Fouche ,  Eric Khorombi ,  Vinesh Jaichand Maharaj

    发明人： Gerda Fouche ,  Eric Khorombi ,  Vinesh Jaichand Maharaj

    IPC分类号： A61K31/365 ,  A61K36/185 ,  A61K9/00

    CPC分类号： A61K36/185 ,  A61K31/365

    摘要： A process for the production of a substance or composition for the therapeutic or prophylactic treatment of erectile dysfunction or the enhancement of libido in a male human or animal subject comprises the step of formulating the substance or composition from at least one of plant material and an extract of plant material of at least one plant species of the family Geraniaceae.

    摘要翻译： 制备用于治疗或预防性治疗雄性人或动物受试者的勃起功能障碍或增强性欲的物质或组合物的方法包括从至少一种植物材料和提取物配制该物质或组合物的步骤 的至少一种家蚕科植物的植物材料。